Zip:  

A successful colonoscopy starts with a complete colonoscopy prep

Colonoscopy is widely used for colorectal cancer screening. Chances are you've heard that preparing for a colonoscopy is no picnic. It's true. The colonoscopy prep process may not be the most glamorous activity, but it is crucial to this potentially lifesaving procedure. That's because an effective colonoscopy prep allows your doctor to examine the entire lining of your colon for abnormal growths, which may grow into cancer if they are not detected and removed.

MoviPrep is a low-volume colonoscopy prep that is proven to help provide a clear view of the entire colon,often allowing your doctor to detect abnormal growths. That's one reason why MoviPrep has been prescribed nearly over 10 million times in the United States since 20061.

Your helpful guide for the colonoscopy prep process

Rest assured, getting a colonoscopy is time well spent toward helping protect your long-term health. To help make the process more tolerable, we created this Web site to help guide you through the weeks and days leading up to your colonoscopy.Within this site, you will find helpful tools, such as the My MoviMent Prep Kit and a sample calendar for the time leading up to your colonoscopy . You can also read about others' experiences and learn more about the colonoscopy prep, colonoscopy, and colon cancer.

Indication for MOVIPREP

MOVIPREP® (PEG-3350, sodium sulfate, sodium chloride, potassium chloride, sodium ascorbate and ascorbic acid for oral solution) is an osmotic laxative indicated for cleansing of the colon as a preparation for colonoscopy in adults 18 years of age or older.

Important Safety Information about MOVIPREP

  • Do not take MOVIPREP® (PEG-3350, sodium sulfate, sodium chloride, potassium chloride, sodium ascorbate and ascorbic acid for oral solution) if you have a gastrointestinal (GI) obstruction (a blockage in your bowel), bowel perforation (an opening in the wall of your stomach or intestine), gastric retention (problems with food and fluid emptying from your stomach), ileus (bowel muscle unable to move stomach contents), toxic colitis (damage to the thickness of the intestinal wall) or toxic megacolon (an extremely dilated or distended colon with fever and/or abdominal pain at times), or if you have a known allergy to MOVIPREP or any of its components.
  • It is important to drink sufficient liquids before, during, and after the use of MOVIPREP. Liquid and blood salt changes can lead to serious side effects including abnormal heartbeats, seizures, and kidney problems. Talk to your doctor before taking MOVIPREP if you take any medications that increase the risk of blood salt abnormalities or if you have known or suspected low blood salt (sodium) level (hyponatremia).
  • If you have kidney problems or if you take medication that affects kidney function, talk to your doctor before taking MOVIPREP.
  • If you have suspected bowel blockage or a suspected opening in the wall of your stomach or intestine, talk to your doctor before taking MOVIPREP.
  • Talk to your doctor before taking MOVIPREP if you have problems swallowing, if you have gastric reflux, or if you are predisposed to aspiration.
  • If you have a condition that destroys red blood cells called glucose-6-phosphate dehydrogenase (G6PD) deficiency, talk to your doctor before taking MOVIPREP.
  • Please be advised that MOVIPREP contains 131 mg of phenylalanine per treatment.
  • If you are pregnant or planning to become pregnant, talk to your doctor before taking MOVIPREP.
  • In clinical studies with MOVIPREP, the most common side effects for split dosing were malaise (feeling uneasy), nausea, stomach (abdominal) pain, vomiting, and upper stomach pain. The most common side effects for evening only dosing were stomach swelling (abdominal distension), anal discomfort, thirst, nausea, stomach (abdominal) pain, sleep disorder, rigors (body shakes), hunger, malaise (feeling uneasy), vomiting, and dizziness.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch/ or call 1-800-FDA-1088.

For product information, adverse event reports, and product complaint reports, please contact:

Salix Product Information Call Center
Phone: 1-800-508-0024
Fax: 1-510-595-8183
Email: salixmc@dlss.com

Please click here for complete Prescribing Information for MOVIPREP. 

References: 1. Symphony Health Solutions, Pharmaceutical Audit Suite (PHAST); September 2006 to July 2016.